Skip to main content
Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancer
Published Web Location
https://www.sciencedirect.com/science/article/pii/S0090825821014980?via%3DihubNo data is associated with this publication.